Ex vivo PD-L1/PD-1 pathway blockade reverses dysfunction of circulating CEA specific T cells in pancreatic cancer patients.

Chen, Y; Xue, S-A; Behboudi, S; Mohammad, GH; Pereira, SP; Morris, E; (2017) Ex vivo PD-L1/PD-1 pathway blockade reverses dysfunction of circulating CEA specific T cells in pancreatic cancer patients. Clin Cancer Res 10.1158/1078-0432.CCR-17-1185 .

http://ift.tt/2uMIVRI